8.09  0.82 (11.28%)		04-27 16:00
Open: 7.17 High: 8.44 Volume: 39,444		Pre. Close: 7.27 Low: 6.842 Market Cap: 6(M)

Short term
Mid term
Targets	6-month :	10.9	1-year :	13.73
Resists	First :	9.33	Second :	11.76
Pivot price	7.78
Supports	First :	5.4	Second :	4.5
MAs	MA(5) :	7.25	MA(20) :	7.69
	MA(100) :	7.47	MA(250) :	35.15
MACD	MACD :	-0.4	Signal :	-0.4
%K %D	K(14,3) :	13.3	D(3) :	19.1
RSI	RSI(14): 45.7
52-week	High :	157.05	Low :	3.07

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ MLEC ] has closed above bottom band by 37.5%. Bollinger Bands are 40.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	7.87 - 7.91	7.91 - 7.94
Low:	6.96 - 7	7 - 7.03
Close:	7.21 - 7.27	7.27 - 7.33

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.

Mon, 27 Apr 2026
MLEC stock extends its relentless rally, sees 35% boost today after change in shareholding - MSN

Wed, 15 Apr 2026
Moolec Science (NASDAQ: MLEC) director discloses option grants in Form 3 - Stock Titan

Wed, 08 Apr 2026
Major Moolec Science (MLEC) investor converts prefs, takes 65.1% stake - Stock Titan

Wed, 08 Apr 2026
What's Going On With Moolec Stock Today? - Moolec Science (NASDAQ:MLEC) - Benzinga

Thu, 02 Apr 2026
AIGC takes control of Moolec Science (MLEC) with 65.1% stake - Stock Titan

Fri, 13 Feb 2026
Moolec Science stock soars after confirming high GLA concentration - Investing.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	1 (M)
Shares Float	0 (M)
Held by Insiders	21 (%)
Held by Institutions	0.2 (%)
Shares Short	2 (K)
Shares Short P.Month	58 (K)

EPS	-258.7
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.69
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-0.03
PEG Ratio	0
Price to Book value	10.44
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.